DUODENAL CANCER

Clinical trials for DUODENAL CANCER explained in plain language.

Never miss a new study

Get alerted when new DUODENAL CANCER trials appear

Sign up with your email to follow new studies for DUODENAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Personalized immune cell therapy aims to stop deadly digestive cancers from coming back

Disease control Terminated

This study aimed to test if a personalized immune cell therapy could prevent or delay the return of advanced gastrointestinal cancers (like pancreatic, liver, or colon cancer) after standard treatment like surgery. It was for patients whose cancer had specific genetic mutations a…

Matched conditions: DUODENAL CANCER

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

DUODENAL CANCER

Get alerted when new DUODENAL CANCER trials appear

Personalized immune cell therapy aims to stop deadly digestive cancers from coming back